Mareike Schell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mareike Schell has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- André Kleinridders
Department of Molecular and Experimental Nutritional Medicine, Institute of Nutritional Science, University of Potsdam, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany
2 shared publications - Michaela Rath
Cellular Physiology of Nutrition, Institute of Nutritional Science, University of Potsdam
2 shared publications - Robert Hauffe
Institute of Nutritional Science, Department of Molecular and Experimental Nutritional Medicine, University of Potsdam, Nuthetal, Germany
2 shared publications Annette Schürmann
German Center for Diabetes Research (DZD), D-85764 München-Neuherberg, Germany; German Institute of Human Nutrition, Research Group Experimental Diabetology, D-14558 Nuthetal, Germany
1 shared publication- Christiane Ott
Department of Molecular Toxicology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany
1 shared publication - Kai Kappert
Institute of Diagnostic Laboratory Medicine, Clinical Chemistry and Pathobiochemistry , Charité – Universitätsmedizin Berlin , Berlin , Germany
1 shared publication
Latest Publications
- 1 April 2023
- Published by Georg Thieme Verlag KG in Diabetologie und Stoffwechsel
- Vol. 18 (S 01) , S2-S3
DEP-1 a Novel Modulator of Energy Metabolism
Obesity is associated with insulin and leptin resistance, which affects peripheral tissues as well as the brain. The novel density-enhanced phosphatase-1 (DEP-1), is a known negative modulator of insulin and leptin signaling. Intriguingly, diet-induced obese mice have increased DEP-1 expression in metabolic sensitive tissues, including the brain. In this study, the regulation of DEP-1-dependent metabolic effects was investigated in vitro and in vivo. To study the functional consequences of DEP-1 deficiency in vitro, we established a DEP-1 knockout (DEP-1 KO) in mouse undifferentiated dopaminergic-like Neuro-2a cells using CRISPR/Cas9. Additionally, we investigated the metabolic consequences of DEP-1 deficiency in the brain by crossing Dep-1 lox/lox mice to forebrain hippocampus-specific CamKIIa Cre mice and fed them a normal chow diet (NCD). DEP-1 KO cells portrayed a significant increase in phospho-ERK signaling upon acute insulin challenge shown by western blot analysis, suggestive of enhanced insulin signalling. Moreover, female DEP-1 KO mice fed a NCD revealed an increase in white-adipose tissue weight along with elevated adipogenic gene markers. On the other hand, male DEP-1 KO mice displayed significant upregulation in brown adipose tissue (BAT) gene markers in addition to an increase in protein expression of the different oxidative phosphorylation complexes subunits, indicating increased oxidative phosphorylation capacity in BAT of male DEP-1 KO mice [1] [2] [3] [4] [5]. This suggests that while in vitro DEP-1 deficiency subtly improves insulin sensitivity, DEP-1 KO mice demonstrate DEP-1 as a potential neuronal modulator of energy metabolism. Article published online: 02 May 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 April 2023
- Published by Georg Thieme Verlag KG in Diabetologie und Stoffwechsel
- Vol. 18 (S 01) , S2-S3
DEP-1 a Novel Modulator of Energy Metabolism
Obesity is associated with insulin and leptin resistance, which affects peripheral tissues as well as the brain. The novel density-enhanced phosphatase-1 (DEP-1), is a known negative modulator of insulin and leptin signaling. Intriguingly, diet-induced obese mice have increased DEP-1 expression in metabolic sensitive tissues, including the brain. In this study, the regulation of DEP-1-dependent metabolic effects was investigated in vitro and in vivo. To study the functional consequences of DEP-1 deficiency in vitro, we established a DEP-1 knockout (DEP-1 KO) in mouse undifferentiated dopaminergic-like Neuro-2a cells using CRISPR/Cas9. Additionally, we investigated the metabolic consequences of DEP-1 deficiency in the brain by crossing Dep-1 lox/lox mice to forebrain hippocampus-specific CamKIIa Cre mice and fed them a normal chow diet (NCD). DEP-1 KO cells portrayed a significant increase in phospho-ERK signaling upon acute insulin challenge shown by western blot analysis, suggestive of enhanced insulin signalling. Moreover, female DEP-1 KO mice fed a NCD revealed an increase in white-adipose tissue weight along with elevated adipogenic gene markers. On the other hand, male DEP-1 KO mice displayed significant upregulation in brown adipose tissue (BAT) gene markers in addition to an increase in protein expression of the different oxidative phosphorylation complexes subunits, indicating increased oxidative phosphorylation capacity in BAT of male DEP-1 KO mice [1] [2] [3] [4] [5]. This suggests that while in vitro DEP-1 deficiency subtly improves insulin sensitivity, DEP-1 KO mice demonstrate DEP-1 as a potential neuronal modulator of energy metabolism. Article published online: 02 May 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 1 November 2021
- Published by Elsevier in Molecular Metabolism
- Vol. 53, 101276
HSP60 reduction protects against diet-induced obesity by modulating energy metabolism in adipose tissue
- 1 November 2021
- Published by Elsevier in Molecular Metabolism
- Vol. 53, 101276
Open AccessHSP60 reduction protects against diet-induced obesity by modulating energy metabolism in adipose tissue